Subscribe To
STXS / Stereotaxis Inc. (STXS) Reports Q4 Loss, Tops Revenue Estimates
STXS News
By GlobeNewsWire
October 17, 2023
Stereotaxis to Report Third Quarter 2023 Financial Results on November 9, 2023
ST. LOUIS, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovas more_horizontal
By Seeking Alpha
August 10, 2023
Stereotaxis, Inc. (STXS) Q2 2023 Earnings Call Transcript
Stereotaxis, Inc. (NYSE:STXS ) Q2 2023 Earnings Conference Call August 10, 2023 10:00 AM ET Company Participants David Fischel - Chairman & Chief Exec more_horizontal
By GlobeNewsWire
July 15, 2023
Stereotaxis to Report Second Quarter 2023 Financial Results on August 10, 2023
ST. LOUIS, July 20, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovas more_horizontal
By Zacks Investment Research
July 11, 2023
Down -32.11% in 4 Weeks, Here's Why You Should You Buy the Dip in Stereotaxis Inc. (STXS)
Stereotaxis Inc. (STXS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement more_horizontal
By GlobeNewsWire
May 25, 2023
Stereotaxis to Participate in 20th Annual Craig-Hallum Institutional Investor Conference
ST. LOUIS, May 25, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovasc more_horizontal
By Seeking Alpha
March 3, 2023
Stereotaxis, Inc. (STXS) Q4 2022 Earnings Call Transcript
Stereotaxis, Inc. (NYSE:STXS ) Q4 2022 Earnings Conference Call March 3, 2023 10:00 AM ET Company Participants David Fischel - CEO & Chairman Kimberly more_horizontal
By GlobeNewsWire
February 21, 2023
Stereotaxis to Present at Cowen 43rd Annual Health Care Conference
ST. LOUIS, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovas more_horizontal
By Seeking Alpha
February 15, 2023
Catalysts Are Coming Soon For Stereotaxis
Stereotaxis, Inc. stock fell in 2022 because of new product delays and weak new orders. These delays and disappointing new orders were caused by macro more_horizontal